Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide first isolated from the cerebral venous blood of rabbits in 1977. Composed of nine amino acids (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu), DSIP has been the subject of extensive preclinical research due to its proposed modulatory effects on sleep architecture, particularly slow-wave (delta) sleep. Beyond sleep regulation, DSIP is thought to interact with the hypothalamic-pituitary axis, influencing the release of hormones including LH, GH, and corticotropin, making it a compound of broad neuroendocrine interest.
In research settings, DSIP has been investigated for its potential antioxidant properties, stress-buffering effects, and interactions with opioid systems. Studies have also explored its role in circadian rhythm modulation and nociception. Its low molecular weight and apparent blood-brain barrier permeability make it a valuable tool for neurological and endocrinological research.
Specifications: Molecular Formula: C₃₅H₄₈N₁₀O₁₅ | Molecular Weight: 848.8 g/mol | Purity: >98% | CAS Number: 62568-57-4 | Form: Lyophilised Powder. Store at -20°C, protected from light and moisture. Reconstitute in bacteriostatic water or sterile saline prior to use.
Molecular Formula
C₃₅H₄₈N₁₀O₁₅
Molecular Weight
848.8 g/mol
Purity
>98%
CAS Number
62568-57-4
Form
Lyophilised Powder
Research Applications
Sleep regulation research, Neuroendocrinology, Circadian rhythm modulation, Stress response studies, Nociception and pain research, Antioxidant mechanism studies
For research purposes only. Not for human use.
Reviews
There are no reviews yet.